Shadlen, Kenneth C.

Number of items: 80.
Article
  • Kyle, Margaret, Sampat, Bhaven N., Shadlen, Kenneth C. (2026). TRIPS, pharmaceutical patents, and generic competition in India. Health Affairs Scholar, 4(2). https://doi.org/10.1093/haschl/qxaf239
  • Massard da Fonseca, Elize, Shadlen, Kenneth C. (2025). Aligning health, industry, and innovation through public procurement. European Journal of Public Health, [In Press] picture_as_pdf
  • Mercadante Santino De Oliveira, Eduardo, Minssen, Timo, Shadlen, Kenneth C., van Zimmeren, Esther, Zemła-Pacud, Żaneta, Matthews, Duncan (2025). A global landscape of patenting activity in COVID-19 vaccines. Vaccine, 67, https://doi.org/10.1016/j.vaccine.2025.127866 picture_as_pdf
  • Contreras, Jorge L., Shadlen, Kenneth C. (2024). Contrasting academic approaches to COVID-19 vaccine production and distribution: what can the Oxford and Texas experiences teach us about pandemic response? Health Affairs Scholar, 2(2). https://doi.org/10.1093/haschl/qxae012 picture_as_pdf
  • Fonseca, Elize Massard da, Shadlen, Kenneth C., De Moraes Achcar, Helena (2023). Vaccine technology transfer in a global health crisis: actors, capabilities, and institutions. Research Policy, 52(4). https://doi.org/10.1016/j.respol.2023.104739 picture_as_pdf
  • Shadlen, Kenneth C. (2022). Accelerating pooled licensing of medicines to enhance global production and equitable access. The Lancet, 400(10352), 632-634. https://doi.org/10.1016/S0140-6736(22)01013-3
  • Massard da Fonseca, Elize, Shadlen, Kenneth C., Inácio Bastos, Francisco (2021). The politics of COVID-19 vaccination in middle-income countries: lessons from Brazil. Social Science and Medicine, 281, https://doi.org/10.1016/j.socscimed.2021.114093 picture_as_pdf
  • Wouters, Olivier J., Shadlen, Kenneth C, Salcher-konrad, Maximilian, Pollard, Andrew J, Larson, Heidi J, Teerawattananon, Yot, Jit, Mark (2021). Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. The Lancet, 397(10278), 1023 - 1034. https://doi.org/10.1016/S0140-6736(21)00306-8 picture_as_pdf
  • Sampat, Bhaven N., Shadlen, Kenneth C. (2021). The COVID-19 innovation system. Health Affairs, 40(3), 400 - 409. https://doi.org/10.1377/hlthaff.2020.02097
  • Shadlen, Kenneth C., Sampat, Bhaven N., Kapczynski, Amy (2020). Patents, trade, and medicines: past, present, and future. Review of International Political Economy, 27(1), 75 - 97. https://doi.org/10.1080/09692290.2019.1624295 picture_as_pdf
  • Gleeson, Deborah, Lexchin, Joel, Labonté, Ronald, Townsend, Belinda, Gagnon, Marc-André, Kohler, Jillian, Forman, Lisa, Shadlen, Kenneth C. (2019). Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts. Globalization and Health, 15(1). https://doi.org/10.1186/s12992-019-0518-2 picture_as_pdf
  • Massard da Fonseca, Elize, Shadlen, Kenneth C., Inácio Bastos, Francisco (2019). Integrating science, technology and health policies in Brazil: incremental change and public health professionals as reform agents. Journal of Latin American Studies, 51(2), 357 - 377. https://doi.org/10.1017/S0022216X18001050
  • Massard da Fonseca, Elize, Shadlen, Kenneth C., Inácio Bastos, Francisco (2019). Brazil’s fight against Hepatitis C: universalism, local production, and patents. New England Journal of Medicine, 380(7), 605-607. https://doi.org/10.1056/NEJMp1812959 picture_as_pdf
  • Shadlen, Kenneth C., Sampat, Bhaven N. (2018). Indian pharmaceutical patent prosecution: the changing role of Section 3(d). PLOS ONE, 13(4). https://doi.org/10.1371/journal.pone.0194714
  • Massard da Fonseca, Elize, Shadlen, Kenneth C. (2017). Promoting and regulating generic medicines: Brazil in comparative perspective. Revista Panamericana de Salud Pública/Pan American Journal of Public Health, 41(e5), 1-6.
  • Sampat, Bhaven N., Shadlen, Kenneth C. (2017). Secondary pharmaceutical patenting: a global perspective. Research Policy, 46(3), 693-707. https://doi.org/10.1016/j.respol.2017.01.005
  • Sampat, Bhaven N., Shadlen, Kenneth C. (2015). Drug patenting in India: looking back andlooking forward. Nature Reviews: Drug Discovery, 14, 519-520. https://doi.org/10.1038/nrd4681
  • Sampat, Bhaven N., Shadlen, Kenneth C. (2015). TRIPS implementation and secondary pharmaceutical patenting in Brazil and India. Studies in Comparative International Development, 50(2), 228-257. https://doi.org/10.1007/s12116-015-9181-7
  • Chorev, Nitsan, Shadlen, Kenneth C. (2015). Intellectual property, access to medicines, and health: new research horizons. Studies in Comparative International Development, 50(2), 143-156. https://doi.org/10.1007/s12116-015-9182-6
  • Manger, Mark S., Shadlen, Kenneth C. (2014). Political trade dependence and North-South trade agreements. International Studies Quarterly, 58(1), 79 - 91. https://doi.org/10.1111/isqu.12048
  • Shadlen, Kenneth C., Massard da Fonseca, Elize (2013). Healthpolicy as industrial policy: Brazil in comparative perspective. Politics & Society, 41(4), 561-587. https://doi.org/10.1177/0032329213507552
  • Shadlen, Kenneth C. (2013). The Patent policy trilemma. Journal Für Entwicklungspolitik, 29(2), 87-105.
  • Sampat, Bhaven N., Shadlen, Kenneth C., Amin, Tahir M. (2012). Challenges to India's pharmaceutical patent laws. Science, 337(6093), 414-415. https://doi.org/10.1126/science.1224892
  • Shadlen, Kenneth C. (2012). The Mexican exception: patents and innovation policy in a non-conformist and reluctant middle income country. European Journal of Development Research, 24(2), 300-318. https://doi.org/10.1057/ejdr.2012.9
  • Shadlen, Kenneth C. (2011). The political contradictions of incremental innovation: lessons from pharmaceutical patent examination in Brazil. Politics & Society, 39(2), 143-174. https://doi.org/10.1177/0032329211402601
  • Shadlen, Kenneth C. (2011). The puzzling politics of patents and innovation policy in Mexico. Law and Business Review of the Americas, 17(1).
  • Shadlen, Kenneth C. (2009). The politics of patents and drugs in Brazil and Mexico: the industrial bases of health policies. Comparative Politics, 42(1), 41-58. https://doi.org/10.5129/001041509X12911362972791
  • Shadlen, Kenneth C. (2008). Policy space for intellectual property management: contrasting multilateral and regional-bilateral arrangements. Econômica, 10(2), 55-81.
  • Shadlen, Kenneth C. (2008). Globalization, power and economic integration: the political economy of regional and bilateral trade agreements in the Americas. The Journal of Development Studies, 44(1), 1-20. https://doi.org/10.1080/13562570701722089
  • Shadlen, Kenneth C. (2007). The political economy of AIDS treatment: intellectual property and the transformation of generic supply. International Studies Quarterly, 51(3), 559-581. https://doi.org/10.1111/j.1468-2478.2007.00464.x
  • Shadlen, Kenneth C. (2007). Intellectual property, trade and development: can foes be friends? Global Governance, 13(2), 171-177.
  • Shadlen, Kenneth C. (2006). Latin American trade and development in the new international economy [review essay]. Latin American Research Review, 41(3), 210-221.
  • Shadlen, Kenneth C., Schrank, Andrew, Kurtz, Marcus J. (2005). The political economy of intellectual property protection: the case of software. International Studies Quarterly, 49(1), 45-71. https://doi.org/10.1111/j.0020-8833.2005.00334.x
  • Shadlen, Kenneth C. (2005). Exchanging development for market access?: deep integration and industrial policy under multilateral and regional-bilateral trade agreements. Review of International Political Economy, 12(5), 750-775. https://doi.org/10.1080/09692290500339685
  • Shadlen, Kenneth C. (2004). Challenges to treatment: the price-infrastructure trap and access to HIV/AIDS drugs. Journal of International Development, 16(8), 1169-1180. https://doi.org/10.1002/jid.1170
  • Shadlen, Kenneth C. (2004). Patents and pills, power and procedure: the North-South politics of public health in the WTO. Studies in Comparative International Development, 39(3), 76-108. https://doi.org/10.1007/BF02686283
  • Shadlen, Kenneth C. (2004). Book review: intellectual property: trade, competition, and sustainable development. World Economy, 27(1), 113-114. https://doi.org/10.1111/j.1467-9701.2004.00591.x
  • Shadlen, Kenneth C. (2002). Orphaned by democracy: small industry in contemporary Mexico. Comparative Politics, 35(1), 43-62.
  • Shadlen, Kenneth C. (2000). Neoliberalism, corporatism, and small business political activism in contemporary Mexico. Latin American Research Review, 35(2), 73-106.
  • Shadlen, Kenneth C. (1999). Continuity amid change: democratization, party strategies and economic policy-making in Mexico. Government and Opposition, 34(3), 397-419. https://doi.org/10.1111/j.1477-7053.1999.tb00488.x
    • Book
  • Shadlen, Kenneth C. (2017). Coalitions and compliance: the political economy of pharmaceutical patents in Latin America. Oxford University Press.
  • Shadlen, Kenneth C., Guennif, Samira, Guzmán, Alenka, Lalitha, N. (Eds.) (2011). Intellectual property, pharmaceuticals and public health: access to drugs in developing countries. Edward Elgar.
  • Haunss, Sebastian, Shadlen, Kenneth C. (Eds.) (2009). Politics of intellectual property: contestation over the ownership, use, and control of knowledge and information. Edward Elgar.
  • Sánchez-Ancochea, Diego, Shadlen, Kenneth C. (Eds.) (2008). The political economy of hemispheric integration: responding to globalization in the Americas. Palgrave Macmillan.
  • Shadlen, Kenneth C. (2004). Democratization without representation: the politics of small industry in contemporary Mexico. Pennsylvania State University Press.
    • Chapter
  • Shadlen, Kenneth C. (2024). Technology transfer for production of COVID-19 vaccines in Latin America. In Sun, H. & Sunder, M. (Eds.), Intellectual Property, COVID-19 and the Next Pandemic: Diagnosing Problems, Developing Cures (pp. 382-412). Cambridge University Press. https://doi.org/10.1017/9781009282406.020
  • Shadlen, Kenneth C. (2013). Is AIDS treatment sustainable? In Aginam, O., Harrington, J. & Yu, P. K. (Eds.), The Global Governance of HIV/AIDS: Intellectual Property and Access to Essential Medicines (pp. 29-58). Edward Elgar.
  • Shadlen, Kenneth C., Guennif, Samira, Guzmán, Alenka, Lalitha, N. (2011). Globalization, intellectual property rights, and pharmaceuticals: meeting the challenges to addressing health gaps in the new international environment. In Shadlen, K. C., Guennif, S., Guzmán, A. & Lalitha, N. (Eds.), Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries (pp. 1-28). Edward Elgar.
  • Shadlen, Kenneth C. (2011). The politics of patents and drugs in Brazil and Mexico: the industrial bases of health policies. In Shadlen, K. C., Guennif, S., Guzmán, A. & Lalitha, N. (Eds.), Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries (pp. 178-201). Edward Elgar.
  • Shadlen, Kenneth C. (2009). Harmonization, differentiation, and development: the case of intellectual property in the global trading regime. In Sacchetti, S. & Sugden, R. (Eds.), Knowledge in the Development of Economies: Institutional Choices Under Globalisation (pp. 44-66). Edward Elgar.
  • Shadlen, Kenneth C. (2009). Intellectual property for development in Mexico. In The Future of North American Trade Policy: Lessons From Nafta (pp. 53-59). The Frederick S. Pardee Center for the Study of the Longer-Range Future, Boston University.
  • Haunss, Sebastian, Shadlen, Kenneth C. (2009). Introduction: rethinking the politics of intellectual property. In Haunss, S. & Shadlen, K. C. (Eds.), Politics of Intellectual Property: Contestation Over the Ownership, Use, and Control of Knowledge and Information (pp. 1-12). Edward Elgar.
  • Shadlen, Kenneth C. (2009). Resources, rules and international political economy: the politics of development in the WTO. In Joseph, S., Kinley, D. & Waincymer, J. (Eds.), The World Trade Organization and Human Rights: Interdisciplinary Perspectives (pp. 109-132). Edward Elgar.
  • Shadlen, Kenneth C. (2009). The post-TRIPS politics of patents in Latin America. In Haunss, S. & Shadlen, K. C. (Eds.), Politics of Intellectual Property: Contestation Over the Ownership, Use, and Control of Knowledge and Information (pp. 13-28). Edward Elgar.
  • Sánchez-Ancochea, Diego, Shadlen, Kenneth C. (2008). Introduction: globalization, integration, and economic development in the Americas. In Sánchez-Ancochea, D. & Shadlen, K. C. (Eds.), The Political Economy of Hemispheric Integration: Responding to Globalization in the Americas (pp. 1-26). Palgrave Macmillan.
  • Shadlen, Ken (2007). Treating AIDS: intellectual property, generic production, and the challenge of stable supply. In Agarwal, M. & Ray, A. S. (Eds.), Globalization and the Millennium Development Goals: Negotiating the Challenge (pp. 190-214). Social Science Press.
  • Shadlen, Kenneth C. (2005). Debt, finance and the IMF: three decades of debt crises in Latin America. In South America, Central America and the Caribbean 2004 (pp. 8-12). Routledge.
  • Shadlen, Kenneth C. (2000). Elections and democratization in Mexico: tax policy in the "opposition" congress. In Nagel, S. S. (Ed.), Handbook of Global Economic Policy (pp. 479-494). CRC Press.
  • Shadlen, Kenneth C. (2000). Industrialization and business cleavages: organizational resources and the institutional roots of business alliances in postwar Argentina and Brazil (1950s-70s). In Cohn, T. H., McBride, S. & Wiseman, J. (Eds.), Power in the Global Era: Grounding Globalization (pp. 67-80). Palgrave Macmillan.
    • Dataset
  • Shadlen, Kenneth C, Sampat, Bhaven N (2016). Implementation and secondary pharmaceutical patenting: Patent data. [Dataset]. UK Data Service. https://doi.org/10.5255/UKDA-SN-852348
  • Shadlen, Kenneth C., Manger, Mark S. (2013). Replication data for: Political Trade Dependence and North-South Trade Agreements. [Dataset]. Harvard Dataverse. https://doi.org/10.7910/dvn/otl76y
  • Shadlen, Kenneth C., Schrank, Andrew, Kurtz, Marcus J. (2007). Replication data for: The Political Economy of Intellectual Property Protection: The Case of Software. [Dataset]. Harvard Dataverse. https://doi.org/10.7910/dvn/cswsut
    • Online resource
  • Shadlen, Kenneth C. (2017). Trade agreements, patents, and drug prices: Continuing the debate.
  • Shadlen, Kenneth C. (2017). On a Quest for universal social policy in the south.
  • Shadlen, Kenneth C. (2016). Debating Patents and Drug Prices: Trade Agreements and the Trans-Pacific Partnership.
  • Shadlen, Kenneth C. (2016). Market Access and the EU Referendum.
  • Shadlen, Kenneth C. (2015). Intellectual Property, Access to Medicines, and Health – Ken Shadlen.
  • Shadlen, Kenneth C. (2015). Ken Shadlen wins Open Article prize for 2014.
  • Shadlen, Kenneth C. (2013). Health policy as industrial policy: Brazil in comparative perspective.
  • Shadlen, Kenneth C. (2013). Learning from India? A new approach to secondary pharmaceutical patents. picture_as_pdf
  • Shadlen, Kenneth C., Sampat, Bhaven N., Amin, Tahir M. (2012). Balancing innovation and access: India’s pharmaceutical patent laws. picture_as_pdf
    • Working paper
  • Kapczynski, Amy, Sampat, Bhaven N., Shadlen, Kenneth C. (2017). Trade agreements, patents, and drug prices: continuing the debate. (Research Paper 572). John M. Olin Center for Studies in Law, Economics, and Public Policy, Yale Law School.
  • Shadlen, Kenneth C. (2005). Policy space for development in the WTO and beyond: the case of intellectual property rights. (Working paper no. 05-06). Global Development and Environment Institute, Tufts University.
  • Shadlen, Kenneth C. (2004). Representation, participation, and development: lessons from small industry in Latin America. (Crisis States Research Centre working papers series 1 45). Crisis States Research Centre, London School of Economics and Political Science.
    • Blog post
  • Shadlen, Ken (5 June 2025) Analysing pharmaceutical patents and researching generic drug policies — and revisiting Mexico City. International Development. picture_as_pdf
  • Shadlen, Kenneth C. (21 January 2025) Trump, tariffs, and international trade politics. International Development. picture_as_pdf
  • Mercadante, Eduardo, Shadlen, Kenneth C. (20 October 2023) Brazilian Patent Office and changes to patenting deadlines. International Development. picture_as_pdf
  • Shadlen, Kenneth C., Azmeh, Shamel (24 May 2023) Rethinking developmental policy space in a fragmented trade regime. International Development. picture_as_pdf
  • Fonseca, Elize Massard da, Shadlen, Kenneth C. (6 July 2021) How political conflicts and a lack of coordination hampered Brazil’s vaccine rollout. LSE COVID-19 Blog. picture_as_pdf
  • Shadlen, Kenneth C., Sampat, Bhaven N. (9 November 2015) Drug patenting in India: looking back and looking forward. South Asia @ LSE. picture_as_pdf
    • This list was generated on Sun Mar 15 09:31:03 2026 GMT.